Physicians practicing in methadone treatment programs: Who are they and what do they do?

Journal of Addictive Diseases

Volumn 23, Issue 2, 2004, Pages 15-31

  Wechsberg, W M ^a   Flannery, B ^a   Kasten, J J ^a   Suerken, C ^a   Dunlap, L ^a   Roussel, A E ^a   Crum, L ^a   Murdoch, O ^a   Diesenhaus, H ^b  

^a RTI INTERNATIONAL   (United States)

^b U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

Administrative duties; Dosing; Methadone maintenance treatment programs; Patient contact; Physicians; Treatment practices

Indexed keywords

METHADONE;

ADULT; AGED; ARTICLE; CAUCASIAN; CLINICAL PRACTICE; CONTROLLED STUDY; DATA ANALYSIS; EXPERIENCE; FEMALE; HEALTH SURVEY; HEROIN DEPENDENCE; HOSPITAL MANAGEMENT; HUMAN; MAINTENANCE DRUG DOSE; MALE; METHADONE TREATMENT; MULTIVARIATE ANALYSIS; NORMAL HUMAN; OUTPATIENT DEPARTMENT; PHYSICIAN; PROFIT; RURAL AREA; TREATMENT OUTCOME; UNITED STATES; URBAN AREA; WORK;

ACCREDITATION; ADULT; ANALGESICS, OPIOID; FEMALE; HEALTH CARE SURVEYS; HUMANS; INSTITUTIONAL PRACTICE; MALE; METHADONE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PATIENT SATISFACTION; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN'S ROLE; PHYSICIAN-PATIENT RELATIONS; RURAL HEALTH SERVICES; SUBSTANCE ABUSE TREATMENT CENTERS; TASK PERFORMANCE AND ANALYSIS; UNITED STATES; URBAN HEALTH SERVICES;

EID: 2442664119     PISSN: 10550887     EISSN: None     Source Type: Journal    
DOI: 10.1300/J069v23n02_02     Document Type: Article

References (24)

1. Institute of Medicine (IOM). Federal regulation of methadone treatment. Washington, DC: National Academy Press, 1995.
2. National Institute of Health (NIH). Effective medical treatment of opiate addiction. NIH Consensus Statement, 1997; 15:1-38.
3. Parrino M. Treatment Improvement Protocol Series (TIPS) 1. State Methadone Treatment Guidelines. Washington, DC: US Government Printing Office, 1993.
4. D'Aunno T, Vaughn TE. Variations in methadone treatment practices: results from a national study. JAMA 1992; 267:253-258.
5. D'Aunno T, Folz-Murphy N, Lin X. Changes in methadone treatment practices: results from a panel study, 1988-1995. Am J Drug Alcohol Abuse 1999; 25:681-699.
6. D'Aunno T, Pollack HA. Changes in methadone treatment practices: results from a national panel study, 1988-2000. JAMA 2002; 288:850-856.
7. Magura S, Nwakeze PC, Demsky SY. Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 1998; 93:51-60.
8. Saxon AJ, Wells EA, Fleming C, Jackson TR, Calsyn DA. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction 1996; 91:1197-1209.
9. Calsyn DA, Saxon AJ, Blaes P, Lee-Meyer S. Staffing patterns of American methadone maintenance programs. J Subst Abuse Treat 1990; 7:255-259.
10. Ball JC, Ross A. The effectiveness of methadone maintenance treatment: patients, programs, services and outcome. New York: Springer-Verlag, 1991.
11. Magura S, Nwakeze PC, Kang SY, Demsky S. Program quality effects on patient outcomes during methadone maintenance: a study of 17 clinics. Subst Use and Misuse 1999; 34:1299-1324.
12. Glezen LA, Lowery CA. Practical issues of program organization and operation. In: Strain EC, Stitzer ML, eds. Methadone treatment for opioid dependence. Baltimore, MD: Johns Hopkins University Press, 1999:237-240.
13. Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. JAMA 1998; 280: 1936-1943.
14. Preston KL, Umbricht A, Epstein DH. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance. Arch of Gen Psychiatry 2000; 57:395-404.
15. Strain EC, Bigelow GE, Liebson IA, Stitzer ML. Moderate- vs. high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA 1999; 281: 1000-1005.
16. Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mt. Sinai Med 2000; 67:347-364.
17. Caplehorn JR, Bell J, Kleinbaum DG, Gebski VJ. Methadone dose and heroin use during maintenance treatment. Addiction 1993; 88:119-124.
18. Maddux JF, Prihoda TJ, Vogtsberger KN. The relationship of methadone dose and other variables to outcomes of methadone maintenance. Am J Addictions 1997; 6:246-255.
19. Caplehorn JR, Bell J. Methadone dosage and retention of patients in maintenance treatment. Medi J Australia 1991; 154:195-199.
20. Payte JT, Khuri ET. Treatment duration and patient retention. State methadone treatment guidelines. Rockville, MD: U.S. Department of Health and Human Services, Center for Substance Abuse Treatment, 1993:119.
21. Leavitt SB, Shinderman M, Maxwell S, Eap CB, Paris P. When "enough" is not enough: new perspectives on optimal methadone maintenance dose. Mt. Sinai Med 2000; 67:404-411.
22. Luckey JW, Graham LA, Phillips CD, Dunn HW, Hubbard RL. Methadone Treatment Quality Assurance System (MTQAS) feasibility study Phase I final report, Vol. 1. Report prepared for National Institute on Drug Abuse (NIDA). Research Triangle Park, NC: Research Triangle Institute, 1995.
23. Center for Substance Abuse Treatment (CSAT). Matching treatment to patient needs in opioid substitution therapy. Treatment Improvement Protocol (TIP) Series, Number 20. Washington, DC: U.S. Government Printing Office, 1995.
24. Center for Substance Abuse Treatment (CSAT). CSAT Guidelines for the accreditation of opioid treatment programs. Rockville, MD: U.S. Department of Health and Human Services, 1999.